ArticleOncotarget2018

Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer.

Karim Boudadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.